People are not good at changing habits, and chronic patients are no exception. This is a massive problem for pharma, bleeding $650B/Yr due to revenue loss. Unfortunately, the proven solution for this adherence problem, applying a human touch to increase accountability, is not scalable. XOLTAR created human-emulating AI for patient accountability and behavioral change support. This mobile platform provides a digital drug companion, allowing patients to interact with AI Accountability Partners in real-time, 24/7. This solution breaks the healthcare industry's engagement-scalability tradeoff, by providing both through proactive video call agents that can engage patients just as care givers do.